Cellavita HD Lower Dose

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
8	ハンチントン病	2

8. ハンチントン病

臨床試験数 : 242 / 薬物数 : 205 - (DrugBank : 62) / 標的遺伝子数 : 85 - 標的パスウェイ数 : 159

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03252535 (ClinicalTrials.gov)	January 15, 2018	15/8/2017	Dose-response Evaluation of the Cellavita HD Product in Patients With Huntington's Disease	Dose-Response Evaluation of the Investigational Product Cellavita HD After Intravenous Administratio ...	Huntington Disease	Biological: Cellavita HD lower dose;Biological: Cellavita HD higher dose;Other: Placebo	Azidus Brasil	Cellavita Pesquisa Científica Ltda	Completed	21 Years	65 Years	All	35	Phase 2	Brazil
2	NCT02728115 (ClinicalTrials.gov)	October 16, 2017	11/3/2016	Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disea ...	First in Human Study to Evaluate Safety of Cellavita HD Investigational Product After Intravenous Ap ...	Huntington Disease	Biological: Cellavita HD Lower Dose;Biological: Cellavita HD Higher dose	Azidus Brasil	Cellavita Pesquisa Científica Ltda;Azidus Brasil Scientific Research and Development Ltda	Active, not recruiting	21 Years	65 Years	Male	6	Phase 1	Brazil

First Previous1Next Last